Fuzeon (Enfuvirtide) for HIV

Overview
Fuzeon is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 in combination with other antiretroviral medications. Fuzeon is approved for use in people who are experiencing HIV replication despite ongoing antiretroviral treatment. Fuzeon is also referred to by its drug name, Enfuvirtide, and by the abbreviation T-30. Fuzeon is an antiviral medication of the fusion inhibitor class. Fuzeon is believed to work by preventing HIV from replicating in cells.

How do I take it?
Prescribing information states that Fuzeon is taken twice daily by subcutaneous injection. Fuzeon comes in vials as a powder.

Side effects
The FDA-approved label for Fuzeon lists common side effects including sleep problems, depression, muscle weakness, fatigue, pain or numbness in the feet and legs, constipation, and pain, irritation, or rash at the injection site.

Rare but serious side effects listed for Fuzeon include hypersensitivity reactions and an increased risk for pneumonia.

For more details about this treatment, visit:

Fuzeon – RxList

Overview of HIV Treatments – AIDS.gov